Dr Anthony Fauci rebukes Trump over claims anti-malaria drug could be coronavirus game-changer

Dr Anthony Fauci has rebuked Donald Trump’s claim that anti-malaria drug chloroquine could be a game-changer in the fight against COVID-19. 

Dr Facui, who is a member of the White House Coronavirus Task Force, made the claim during an interview with Anderson Cooper on CNN Thursday evening.

‘There’s no magic drug for coronavirus right now,’ the top doctor told Cooper. 

Earlier in the day, Trump told media that there had been positive results after doctors trialled chloroquine on COVID-19 patients, and suggested the drug could be a game-changer. 

‘We’re going to be able to make that drug available almost immediately, and that’s where the FDA (Food and Drug Administration) has been so great,’ the President stated.  

However, Dr Fauci declared on CNN: ‘Let me put it into perspective for the viewers .. there has been anecdotal non-proven data that it [chloroquine] works… but when you have an uncontrolled trial you can never definitely say that it works’.

He repeated his caution on Friday in an interview with Today: ‘Even though the information is anecdotal that they may work, we need to prove it so people would get the right drug that’s safe and effective. 

‘What we’re saying is these are drugs that have some suggestion that they may work,’ he went on, but that controlled trials needed to be done to prove that they are effective.  

Dr Anthony Facui, who is a member of the White House Coronavirus Task Force, told CNN Thursday that there was currently no 'magic drug' for COVID-19

Dr Anthony Facui, who is a member of the White House Coronavirus Task Force, told CNN Thursday that there was currently no ‘magic drug’ for COVID-19

Fauci said the government was working on more clinical trials with the drug. 

‘We’re going to try to get them available in the context of some sort of a protocol where you just don’t distribute drugs willy-nilly. You may make it more accessible than you would have previously, but… get some feel for safety and whether it works.

‘Today there are no proven safe and effective therapies for the coronavirus,’ he concluded. 

The University of Minnesota is looking for people who have been in contact with a known positive case of COVID-19 to volunteer for a trial to test Hydroxychloroquine and see if it is effective in preventing people from catching the virus. 

They need 1,500 people to take part in the trial and so far have 150. 

In an interview on Friday morning on Good Morning America, Dr. David R Boulware, who is leading the trial, said they do not yet know if it works and that President Trump got ‘very excited’ about it. 

The university is asking people who think they may be eligible to take part to email [email protected] for more information. 

Side effects of the long-term use of chloroquine include irreversibe damage the retina, as signalled by trouble focusing, eye swelling or color changes. 

The drug can cause strange, bad and vivid dreams and difficulty sleeping. 

Taking chloroquine can also cause your heart to race, trigger headache, fainting, severe dizziness, nausea, a slow heart rate or weak pulse, muscle weakness, numbness and tingly, anxiety and irritability and low blood counts. 

Still, with the death toll of coronavirus nearing 200 in the US, even a drug with significant side effects would be cause for hope in the battle against coronavirus, for which there are currently no proven treatments. 

South Korea’s COVID-19 task force went so far as to say that studies on the drug demonstrated it had ‘certain curative effect’ and ‘fairly good efficacy.’   

Patients treated with hydroxychloroquine improved more quickly and broke their fevers earlier than those who did not receive the drug. 

The drug is also included in China’s treatment guidelines for COVID-19 – described there as ‘chloroquine phosphate – for use in patients between 18 and 65. 

It is one of five antivirals suggested in the 7th edition of China’s treatment plan, which also cautions the drug should not be given to patients with heart disease, as it has potential cardiac side effects. 

Meanwhile, many CNN viewers applauded Dr. Fauci for rebuking Trump’s claim that the drug would be made available almost immediately.  

‘The grim reality … Trump won’t like this,’ one wrote on Twitter. 

‘Threw cold water on the optimism Trump provided,’ another added. 

One even stated that they believed Dr. Fauci was staying away from Trump’s press briefings because of tensions between the pair. 

Dr. Facui has been dubbed as ‘the truth teller’ in Trump’s White House Coronavirus Task Force, and has publicly contradicted the President on a number of occasions. 

‘You should never destroy your own credibility. And you don’t want to go to war with a president … But you got to walk the fine balance of making sure you continue to tell the truth,’ he told Politico last week. 

Last week, the top doctor stated it would be advisable for Trump to have a coronavirus test after he was in contact with a Brazilian politician who was diagnosed with COVID-19. Trump has previously disputed claims that he needed to get a test. 

Meanwhile, late last month Dr. Fauci denied he had been ‘muzzled’ by the Trump Administration for bluntly discussing the seriousness of the coronavirus. 

‘I have never been muzzled ever and I’ve been doing this since the administration of Ronald Reagan, I’m not being muzzled by this administration,’ Dr. Fauci stated. 

Trump similarly stated: ‘He has had that ability to do virtually whatever he’s wanted to do’. 

The number of coronavirus cases in the US has dramatically increased in the last two weeks

The number of coronavirus cases in the US has dramatically increased in the last two weeks

Twitter users took note of how quickly Trump's mistaken announcement about the drug was undone

Twitter users took note of how quickly Trump’s mistaken announcement about the drug was undone 

HOW THE ANTI-MALARIA DRUG IS USED ABROAD TO TREAT CORONAVIRUS 

A version of the drug the US is now testing, chloronoquine, is already part of the recommended course of treatment in China. 

It is one of five antivirals included in the 7th edition of the countries guidance on caring for coronavirus patients. 

Scientists there have reported that it alleviated symptoms, shorten the duration of the illness, and patients who take it seem to break their fevers earlier. 

Chloroquine is also being used widely in South Korea, where officials have gone so far as to say it has ‘a certain curative effect’ and ‘fairly good efficacy’ in coronavirus patients.  

The World Health Organization has also launched a large-scale trial of a number of potential coronavirus treatments, including chloroquine. 

It will be tested in patients in Argentina, Bahrain, Canada, France, Iran, Norway, South Africa, Spain, Switzerland and Thailand and perhaps others. The US is not slated for inclusion. 

Already in France, the drug has been tested in 36 patients.

Hydroxychloroquine, the form of the drug that will now be used ‘compassionately’ in the US, was given to 24 out of 36 trial participants. Half of them cleared the infection entirely, according to an early announcement of the results on Wednesday.